Physician

Anthony Chiaravalloti, MD

According to 2025 Medicare claims, Anthony Chiaravalloti, MD (NPI: 1598178378) practices dermatology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Onondaga, NY. This provider's primary affiliated billing organization is AUBURN DERMATOLOGY PLLC (NPI: 1275221053; TIN: 922678513) and primary practice location at 13057-9998.

Chiaravalloti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 547 traditional Medicare patients, billed 2,280 HCPCS/CPT codes, and received $548,927 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 78 prescription claims across 39 beneficiaries totaling $310,181 in drug costs, led by Odomzo (Sonidegib Phosphate). Open Payments data shows 143 records totaling $37,500. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $93,604 to $548,927. Similarly, Part D prescription costs have risen steadily, from $6,316 to $310,181. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$293K$587K2019 Medicare payment: $93,604 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $409,803 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $480,623 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $583,792 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $586,653 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $548,927 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019195621$93,604
20204742,001$409,803
20215062,420$480,623
20225782,706$583,792
20235542,472$586,653
20245472,280$548,927

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$224K$449K2015 Drug cost: $6,316 (USD; Tot_Drug_Cst)2016 Drug cost: $42,209 (USD; Tot_Drug_Cst)2017 Drug cost: $56,675 (USD; Tot_Drug_Cst)2018 Drug cost: $43,666 (USD; Tot_Drug_Cst)2019 Drug cost: $54,878 (USD; Tot_Drug_Cst)2020 Drug cost: $116,235 (USD; Tot_Drug_Cst)2021 Drug cost: $345,449 (USD; Tot_Drug_Cst)2022 Drug cost: $348,433 (USD; Tot_Drug_Cst)2023 Drug cost: $448,807 (USD; Tot_Drug_Cst)2024 Drug cost: $310,181 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201538121$6,316
20163392$42,209
20172552$56,675
201895182$43,666
2019151287$54,878
2020105197$116,235
2021114190$345,449
202293152$348,433
202358120$448,807
20243978$310,181

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks448554$415
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks290438$280
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm173191$161
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more6363$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more101144$59

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OdomzoSonidegib Phosphate16480$220,967
Humira(Cf) PenAdalimumab13364$88,550
Doxycycline HyclateDoxycycline Hyclate11114$48
CephalexinCephalexin15105$31

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.143$37,500MIMEDX Group, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anthony Chiaravalloti, MD?

Tedicare shows public-source Medicare data for Anthony Chiaravalloti, MD (NPI 1598178378), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Chiaravalloti, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony Chiaravalloti, MD?

Anthony Chiaravalloti, MD is linked to AUBURN DERMATOLOGY PLLC (billing NPI 1275221053) in the available physician profile data.

Does Anthony Chiaravalloti, MD have Open Payments data?

Anthony Chiaravalloti, MD has 143 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.